115 related articles for article (PubMed ID: 32357309)
1. CRISP3 expression drives prostate cancer invasion and progression.
Volpert M; Furic L; Hu J; O'Connor AE; Rebello RJ; Keerthikumar S; Evans J; Merriner DJ; Pedersen J; Risbridger GP; McIntyre P; O'Bryan MK
Endocr Relat Cancer; 2020 Jul; 27(7):415-430. PubMed ID: 32357309
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.
Pathak BR; Breed AA; Deshmukh P; Mahale SD
J Steroid Biochem Mol Biol; 2018 Jul; 181():20-27. PubMed ID: 29477539
[TBL] [Abstract][Full Text] [Related]
3. Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
Dahlman A; Edsjö A; Halldén C; Persson JL; Fine SW; Lilja H; Gerald W; Bjartell A
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):369-75. PubMed ID: 20680031
[TBL] [Abstract][Full Text] [Related]
4. Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma.
Wang Y; Sheng N; Xie Y; Chen S; Lu J; Zhang Z; Shan Q; Wu D; Zheng G; Li M; Zheng Y; Fan S
J Cell Physiol; 2019 Aug; 234(8):13629-13638. PubMed ID: 30609035
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
[TBL] [Abstract][Full Text] [Related]
6. Endometrial CRISP3 is regulated throughout the mouse estrous and human menstrual cycle and facilitates adhesion and proliferation of endometrial epithelial cells.
Evans J; D'Sylva R; Volpert M; Jamsai D; Merriner DJ; Nie G; Salamonsen LA; O'Bryan MK
Biol Reprod; 2015 Apr; 92(4):99. PubMed ID: 25715794
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
Van Eynde A; Litovkin K; Bollen M
Asian J Androl; 2011 Mar; 13(2):205-6. PubMed ID: 21102472
[No Abstract] [Full Text] [Related]
8. Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.
Pathak BR; Breed AA; Nakhawa VH; Jagtap DD; Mahale SD
Asian J Androl; 2010 Sep; 12(5):677-89. PubMed ID: 20676114
[TBL] [Abstract][Full Text] [Related]
9. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.
Pathak BR; Breed AA; Apte S; Acharya K; Mahale SD
Mol Cell Biochem; 2016 Jan; 411(1-2):11-21. PubMed ID: 26369530
[TBL] [Abstract][Full Text] [Related]
10. MiR-182-5p, MiR-192-5p, and MiR-493-5p Constitute a Regulatory Network with CRISP3 in Seminal Plasma Fluid of Teratozoospermia Patients.
Gholami D; Amirmahani F; Yazdi RS; Hasheminia T; Teimori H
Reprod Sci; 2021 Jul; 28(7):2060-2069. PubMed ID: 33620707
[TBL] [Abstract][Full Text] [Related]
11. The expression of β-microseminoprotein but not CRISP3 is reduced in ovarian cancer and correlates to survival.
Henriksen R; Lundwall Å; Udby L; Fernlund P
Anticancer Res; 2012 Sep; 32(9):3993-9. PubMed ID: 22993349
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
Hoogland AM; Dahlman A; Vissers KJ; Wolters T; Schröder FH; Roobol MJ; Bjartell AS; van Leenders GJ
BJU Int; 2011 Oct; 108(8):1356-62. PubMed ID: 21410630
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of CRISP-3 from human seminal plasma and its real-time binding kinetics with PSP94.
Anklesaria JH; Pandya RR; Pathak BR; Mahale SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():59-65. PubMed ID: 27825912
[TBL] [Abstract][Full Text] [Related]
14. beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
Udby L; Lundwall A; Johnsen AH; Fernlund P; Valtonen-André C; Blom AM; Lilja H; Borregaard N; Kjeldsen L; Bjartell A
Biochem Biophys Res Commun; 2005 Jul; 333(2):555-61. PubMed ID: 15950934
[TBL] [Abstract][Full Text] [Related]
15. Cysteine-rich secretory protein 3 inhibits hepatitis C virus at the initial phase of infection.
Lee U; Nam YR; Ye JS; Lee KJ; Kim N; Joo CH
Biochem Biophys Res Commun; 2014 Jul; 450(2):1076-82. PubMed ID: 24978310
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.
Kosari F; Asmann YW; Cheville JC; Vasmatzis G
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1419-26. PubMed ID: 12433721
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
Bjartell A; Johansson R; Björk T; Gadaleanu V; Lundwall A; Lilja H; Kjeldsen L; Udby L
Prostate; 2006 May; 66(6):591-603. PubMed ID: 16388501
[TBL] [Abstract][Full Text] [Related]
19. Identification of CRISP2 from human sperm as PSP94-binding protein and generation of CRISP2-specific anti-peptide antibodies.
Anklesaria JH; Kulkarni BJ; Pathak BR; Mahale SD
J Pept Sci; 2016 Jun; 22(6):383-90. PubMed ID: 27161017
[TBL] [Abstract][Full Text] [Related]
20. Cysteine-rich secretory protein 3: inflammation role in adult varicocoele.
Belardin L; Camargo M; Intasqui P; Antoniassi M; Fraietta R; Bertolla R
Andrology; 2019 Jan; 7(1):53-61. PubMed ID: 30354034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
